Table 3.
Variable | β (SE) | OR (95% CI) | P |
---|---|---|---|
Intercept | − 2.32 (0.102) | – | – |
Obesity | − 0.23 (0.115) | 0.80 (0.64–0.99) | 0.048 |
Age (standardized) | 0.28 (0.054) | 1.32 (1.19–1.47) | < 0.001 |
Sex, male | 0.10 (0.098) | 1.11 (0.91–1.34) | 0.30 |
Ethnicity | |||
Caucasian | reference | ||
Asian | − 0.04 (0.784) | 0.96 (0.21–4.47) | 0.96 |
Black | 0.39 (0.575) | 1.48 (0.48–4.56) | 0.50 |
Other | − 0.31 (0.448) | 0.73 (0.31–1.76) | 0.49 |
Income (standardized) | − 0.06 (0.044) | 0.95 (0.87–1.03) | 0.20 |
Smoking status | |||
Never-smoker | reference | ||
Ex-smoker > 1 year | 0.02 (0.109) | 1.02 (0.82–1.26) | 0.87 |
Ex-smoker < 1 year | 0.46 (0.218) | 1.59 (1.04–2.44) | 0.033 |
Current smoker | 0.18 (0.131) | 1.20 (0.93–1.56) | 0.16 |
Alcohol consumption | |||
Abstinent | reference | ||
Social | − 0.31 (0.109) | 0.73 (0.59–0.91) | 0.004 |
Problematic | 0.39 (0.139) | 1.47 (1.12–1.94) | 0.005 |
Physical activity | |||
No restriction | reference | ||
Limited | 0.55 (0.095) | 1.74 (1.45–2.10) | < 0.001 |
Chair-ridden | 1.05 (0.167) | 2.87 (2.07–3.98) | < 0.001 |
Bed-ridden | 1.21 (0.214) | 3.34 (2.20–5.09) | < 0.001 |
Hypothyroidism | 0.03 (0.193) | 1.03 (0.70–1.50) | 0.89 |
Chronic glucocorticoids | 0.28 (0.149) | 1.33 (0.99–1.78) | 0.056 |
Solid malignancy | |||
None | reference | ||
Non-metastatic | − 0.10 (0.125) | 0.90 (0.71–1.15) | 0.41 |
Metastatic | 0.23 (0.161) | 1.26 (0.92–1.73) | 0.15 |
Hematologic malignancy | |||
None | reference | ||
Acute lymphoblastic leukemia | 0.29 (0.647) | 1.33 (0.37–4.73) | 0.66 |
Acute myeloid leukemia | 0.88 (0.374) | 2.41 (1.16–5.01) | 0.019 |
Chronic lymphocytic leukemia | 1.28 (0.440) | 2.59 (1.51–8.50) | 0.004 |
Multiple myeloma | 0.66 (0.458) | 1.93 (0.79–4.75) | 0.15 |
Non-Hodgkin lymphoma | 0.41 (0.359) | 1.50 (0.74–3.04) | 0.26 |
Other | 0.74 (0.223) | 2.11 (1.36–3.26) | < 0.001 |
Dementia | 0.04 (0.245) | 1.04 (0.64–1.68) | 0.88 |
HIV/AIDS | − 0.63 (0.619) | 0.53 (0.16–1.80) | 0.31 |
Calendar time (standardized) | 0.05 (0.043) | 1.05 (0.96–1.14) | 0.26 |
AIDS acquired immunodeficiency syndrome, CI confidence interval, HIV human immunodeficiency virus, OR odds ratio, SE standard error